Published in:
01-07-2019 | Mastectomy | Original Article – Clinical Oncology
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast
Authors:
Maria Cristina Leonardi, Ruggero Spoto, Eleonora Miglietta, Sara Trivellato, Eliana La Rocca, Rosa Luraschi, Paola Grosso, Francesca De Lorenzi, Cristiana Fodor, Samantha Dicuonzo, Veronica Dell’Acqua, Marianna Alessandra Gerardi, Anna Morra, Claudia Maria Francia, Mario Rietjens, Viviana Enrica Galimberti, Paolo Veronesi, Roberto Orecchia, Federica Cattani, Barbara Alicja Jereczek-Fossa
Published in:
Journal of Cancer Research and Clinical Oncology
|
Issue 7/2019
Login to get access
Abstract
Purpose
To report the dosimetric feasibility of the radiation technique HALFMOON (Helical ALtered Fractionation for iMplant partial OmissiON) for post-mastectomy radiation therapy (PMRT) in intermediate–high-risk breast cancer patients with implant-based immediate breast reconstruction, where the clinical target volume (CTV) does not include the whole implant (implant-sparing approach).
Methods
In the HALFMOON technique, the CTV consisted of skin, subcutaneous tissues, and pectoralis major muscle, excluding the implant, chest wall muscles, and rib plane. The HALFMOON plans were compared with conventionally contoured CTV plans, in which the whole implant, chest wall muscles, and ribs plane were included in the CTV, in a ratio 1:3. All patients underwent hypofractionated treatment of 40.05 Gy/15 fractions, using helical Tomotherapy®.
Results
Eighteen patients undergoing HALFMOON technique were compared to 54 subjects treated with conventionally contoured CTV plans. No difference was found in the planning target volume coverage between the two groups. Conversely, a statistically relevant dose reduction in HALFMOON patients was observed for ipsilateral lung (D15%, p < 0.0001; D20%, p < 0.0001; D35%, p = 0.003), contralateral lung (D20%, p = 0.048), contralateral breast (D15%, p = 0.031; D20%, p = 0.047), and stomach (Dmean, p = 0.011). Regarding the implant, V90% and D50% decreased by 46% and 8%, respectively, in the HALFMOON plans (p < 0.0001).
Conclusion
The HALFMOON approach is technically feasible and resulted in high-dose conformity of the target with a significant reduction of radiation dose delivered to implant and other organs. A clinical study is needed to assess the impact on reconstruction cosmetic outcome and local control.